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Background: The epidemiology of infection with multiple human papillomavirus (HPV) types in female adolescents
is poorly understood. The purpose of this study was to explore the epidemiology of infection with multiple HPV
types in adolescents and its association with demographic, behavioral and biological variables, as well as with
cytological abnormalities.
Methods: This community-based study included 432 sexually active females between 15 and 19 years of age.
Genotyping for 30 HPV types was performed using a reverse blot strip assay/restriction fragment length polymorphism.
Unconditional multivariate logistic regression was performed to identify factors significantly associated with HPV
infection. The association between HPV infection and cytological abnormalities was calculated using a prevalence ratio.
Results: The most common HPV types detected were 16, 51, 31, 52 and 18. Of the 121 HPV-positive women, 54 (44.6%)
were infected with multiple HPV types. Having more than one lifetime sexual partner was associated with infection
with any HPV infection, single HPV infection, and infection with multiple HPV types. The presence of cytological
abnormalities was associated with infection with multiple HPV types.
Conclusions: Co-infecting HPV genotypes occur in a high proportion of sexually active adolescents. Socio-demographic
or sexual behavior factors associated with single HPV infection were similar to those associated with multiple HPV types.
The higher risk of cytological abnormalities conferred by infection with multiple HPV types suggests a potential role of
co-infection in the natural history of HPV infection.
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Human papillomavirus (HPV) cervical infection is one of
the world’s most common sexually transmitted infections,
and is also a well-established cause of cervical cancer
[1,2]. The highest prevalence of single or co-infection with
multiple HPV types has been found in sexually active
adolescents, young women [3-7], and women with impaired
immune responses [8].
Studies of the dynamics of multiple HPV infections
suggest that the acquisition of different HPV types occurs
more often than expected by chance, and shared risk
factors may explain the higher frequency of co-infections
[9,10]. According to previous studies, the risk factors
for cervical infection with multiple HPV types among
HPV-infected women share several similarities with risk
factors for HPV infection in general [6,7]. In addition, pre-
vious studies suggest that Chlamydia trachomatis infection
can provide target host cells for the acquisition of HPV and
may enable persistent HPV infection [6,11].
HPV infections and cytological abnormalities are
common in adolescents, appearing shortly after the onset
of sexual activity. More than 90% of HPV infections and
cytological abnormalities regress within 3 years [12,13].
Co-infection with multiple HPV types has been associated
with longer infection duration and a higher risk of
cytological abnormalities and cervical neoplasia [3,14-16].
However, a consensus concerning these associations has
not been reached [2,5,17].
Data on HPV infection and cytological abnormalities
in adolescents derived from non-healthcare settings are
scarce, especially in South America [18,19], and particularly
in the mid-western region of Brazil [20]. The recent avail-
ability of a vaccine against HPV infection is a promising pri-
mary prevention measure to reduce the burden of cervical
cancer. Therefore, a description of the genotype distribution
of multiple HPV infections and the prevalence and degree
of cytological abnormalities in sexually active adolescents is
necessary for characterizing the target population for this
vaccine as well as reinforcing the recommendation for
cervical cancer screening in this age group.
The objectives of this study were to estimate the
prevalence, describe the genotype profile and identify
the risk factors for multiple HPV infections among
healthy adolescents in the central part of Brazil, prior to
the implementation of a large-scale HPV immunization
program. Additionally, the study aimed to investigate the
potential association between multiple HPV infections
and cytological abnormalities among adolescents from a
non-healthcare setting.
Methods
Study design and setting
This was a cross-sectional, community-based study. The
design and population characteristics of this study havebeen described previously [21]. Briefly, this study was
conducted between 2002 and 2003 in the Northwest sector
of Goiânia, a city of 1,093,007 inhabitants in the central part
of Brazil. The overall population of the Northwest sector
was approximately 160,030 inhabitants. During the study
period, a total of 4,091 females aged 15–19 years were
registered at the local Public Family Health Program.
Study population and sampling
Households with potential participants were randomly
selected from census information provided by the local
health department using a systematic sampling scheme.
All female adolescents in each selected household were
invited by letter to attend the health center nearest to their
residence. Among the 914 adolescents who accepted the
invitation, 472 (51.6%) were sexually active. The adolescents
were eligible if they were between 15 and 19 years of age,
were not currently pregnant or postpartum, had not
used oral or vaginal antimicrobial drugs in the previous 15
days and had not engaged in sexual intercourse in the previ-
ous 48 hours. In total, 432 adolescents fulfilled the require-
ments, answered an interviewer-administered questionnaire
and had a gynecological examination.
All participants provided written informed consent to
participate in the study. The study was reviewed and
approved by the Ethics Committee on Human and
Animal Medical Research of the University Hospital,
Federal University of Goiás.
Data collection
The data were obtained through an interviewer-administered
questionnaire addressing sociodemographic characteristics
(age, education, marital status), tobacco smoking habits, as
well as the subject’s sexual, gynecological and reproductive
history, including age at menarche, age at first intercourse,
interval in years between the age of first intercourse and the
age of menarche, lifetime number of sexual partners, number
of new sexual partners in the previous 3 months, frequency
of condom use, history of full-term pregnancies and age of
first pregnancy.
The cervical samples collected during the gynecological
examinations were used for Papanicolaou tests, HPV
and C. trachomatis DNA detection. Ectocervical and
endocervical cells were collected with a cytobrush,
which was then immersed in 10 mM Tris (pH 7.4 plus 1
mM EDTA), refrigerated and transported to the laboratory
of Tropical Pathology and Public Health, Federal University
of Goiás, and stored at −80°C until analysis to detect HPV
and C. trachomatis.
C. trachomatis DNA detection was performed by PCR
with primer pairs CP24 and CP27, which amplify a 207
nucleotide sequence of the cryptic plasmid. Positive and
negative controls were included in each assay. An internal
control was conducted in each amplification reaction
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Department of Immunology, Tropical Pathology and
Public Health Institute/Federal University of Goiás.
Papanicolaou smears were transported to and interpreted
in the Pathology and Anatomy University Laboratory, in
accordance with the 2001 Bethesda System [22]. Cytology
assessments were conducted blind to the results of the
exposure status.
Detection of specific HPV types by polymerase chain
reaction (PCR)/reverse blot strip assay/restriction
fragment length polymorphism (RFLP)
DNA was extracted using phenol chloroform and amplified
using PGMY09/11 HPV specific primers that amplify a
450-bp fragment of the L1 open reading frame of genital
HPV [23]. DNA typing with a reverse line blot assay
(Roche Molecular Systems) permitted the identification of
27 individual genital HPV types (6, 11, 16, 18, 26, 31, 33,
35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 56, 57, 58, 59, 66, 68,
73, 82, 83 and 84). The assay was performed following the
manufacturer’s guidelines at the Virology Unit of the São
Paulo Branch of the Ludwig Institute for Cancer Research.
RFLP analysis of the same 450-bp PCR fragment was also
undertaken for some specimens [24]. DNA isolated from
HPV-16 positive SiHa cells was used as a positive control,
while negative controls were included to monitor potential
PCR contamination. To confirm the integrity of the DNA
material extracted from the specimens, assays included an
additional set of primers (GH20 and PC04) to amplify a
268-bp region of the β-globin gene.
Sample size and statistical analysis
A sample size of 430 participants was calculated to provide
enough power to estimate a 10% prevalence of multiple
HPV infections, with a precision of 3.0% and confidence
interval of 95%, with a design effect of 1.2.
The prevalence of single HPV infection and multiple
HPV infections (detection of more than one HPV type per
sample) and their respective 95% confidence intervals (CIs)
were calculated. Socio-demographic and sexual behaviors
variables that were normally distributed were presented as
mean and standard deviation (sd) and were categorized
based on their mean values. Variables that were asym-
metrically distributed were presented as median and
interquartile range (IQR, Q1–Q3). Dichotomization of
asymmetric variables was based on their median value. Years
of schooling were dichotomized at 8 years, corresponding to
the elementary Brazilian school period.
Potential risk factors for HPV infection were assessed
using univariate and multivariate logistic regression
analyses. Three different outcomes were analyzed: any
HPV infection, single HPV infection, or infection with
multiple HPV types. The three outcomes were each
compared with non-infected participants, by calculatingunadjusted and adjusted odds ratios (ORs) with respective
95% CIs. Variables with p < 0.20 in univariate analysis
were included in multivariate models. Participants’ age
was included in all models as a continuous variable, because
age could be a confounding factor for HPV infection.
The association between HPV infection and cytological
abnormalities was calculated using prevalence ratios
and respective 95% CIs. All analyses were conducted
with SPSS, version 16 for Windows. Differences were
considered to be statistically significant when p < 0.05.
Results
Baseline characteristics
In total, 432 adolescents fulfilled the inclusion criteria
and were interviewed. The participants’ mean age was
17.2 years, with a standard deviation of 1.3 years;
approximately 88.0% were from low income families,
67.4% were unmarried, 57.3% reported 8 years of
schooling or less, and 11.6% reported tobacco use.
First sexual intercourse occurred at or before 15 years
of age for 61.1% of the adolescents in this study.
Almost 80.0% of participants reported inconsistent
use of condoms by their partners and 46.0% reported
more than one lifetime sexual partner. Furthermore,
41.7% of participants reported a previous pregnancy,
with 19.0% conceiving before they were 15 years old
(Table 1).
The prevalence of C. trachomatis infection was
13.9% (95% CI: 10.8–17.6). The prevalence of cytological
abnormalities was 15.4% (95% CI: 12.3–19.4), with
atypical squamous cells of undetermined significance
occurring in 10.6% (95% CI: 8.0–14.0), low-grade squa-
mous intraepithelial lesion occurring in 4.6% (95% CI:
2.9–7.2) and atypical squamous cells cannot exclude high-
grade intraepithelial lesion occurring in 0.2% (95% CI:
0.0–1.5) of adolescents. No participant had high-grade
squamous intraepithelial lesion or “atypical” glandular
cells (Table 1).
Prevalence and classification of HPV infection
HPV DNA was detected in cervical specimens of 121 of
the 432 adolescents, resulting in an overall prevalence of
28.0% (95% CI: 23.9–32.5; Table 2). The number of HPV
types detected per specimen ranged from 0 to 5. Among
the 121 HPV-infected participants, a single type of
HPV infection was detected in 67 individuals, whereas
multiple HPV types were detected in 54 adolescents
(54/432; 12.5%), representing 44.6% of the positive
samples (Table 2).
Thirty different HPV types were detected; nineteen
types were high-risk (HR)-HPV (16, 18, 26, 31, 33, 35,
39, 45, 51, 52, 53, 54, 56, 58, 66, 68, 70, 73 and 82), and
11 were low-risk (LR)-HPV types (6, 11, 40, 42, 44, 54,
55, 61, 62, 84, 89), according to the International
Table 1 Characteristics of participants
Characteristics Values
Age (years)
Range 15 to 19
Mean (sd) 17.2 (1.3)
Education (years) a
≤ 8 years (%) 247 (57.3)
> 8 years (%) 184 (42.7)
Marital status
Unmarried (%) 291 (64.4)
Married (%) 141(35.6)
Family income (minimum wages)b
≤ 4 (%) 359 (88.0)
> 4 (%) 49 (12.0)
Smoking
Yes (%) 50 (11.6)
Age at menarche (years)
Range 9 to 17
Mean (sd) 12.5 (1.3)
Age at first intercourse (years)
Range 10 to 19
Mean (sd) 15.1 (1.5)
Number of lifetime sexual partners
Range 1 to 20
Median (IQR Q1-Q3) 1 (1–3)
New sexual partner in past 3 months
Yes (%) 63 (14.6)
Number of sexual partner in past 3 months
Range 1 to 5
Median (IQR Q1-Q3) 1 (1–1)
Condom use
Never/occasional (%) 345 (79.9%)
Always (%) 87 (20.1)
History of full-term pregnancies
Yes (%) 180 (41.7)
Age at first full-term pregnancy (years) c
Range 12 to 19
Mean (sd) 15.6 (1.4)
Chlamydia trachomatis infection (%) 60 (13.9)
Table 1 Characteristics of participants (Continued)
Cytological abnormalities
Overall (%) 67 (15.4)
ASC-US (%) 46 (10.6)
LGSIL (%) 20 (4.6)
ASC-H (%) 1 (0.2)
sd: Standard deviation; IQR, Q1-Q3 interquartile range; a one adolescent without
information; b 24 adolescents without information; MW = 334 US$; c four
adolescents without information; ASCUS: atypical squamous cells of undetermined
significance; ASC-H, atypical squamous cells cannot exclude high-grade
intraepithelial lesion; LGSIL: low-grade squamous intraepithelial lesion.
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shows the absolute frequency of the 30 different HPV
types detected. These types were stratified by multiple
(black bars) and by single (gray bars) infection (Figure 1).
The prevalence of HR-HPV was 24.8% (CI: 20.8–29.2),
which was higher than the LR-HPV type prevalence
(Table 2).
The most prevalent HPV types were 16, 51, 31, 52 and
18, and the most common HPV types detected in
multiple infections included 16, 51, 18, 31 and 52. The
most common HPV type detected in single or multiple
infections was HPV-16; HPV-6 was the most common
LR-HPV detected (Figure 1). The prevalence of either
HR-HPV type that is present in bivalent vaccines
(HPV types 16 and 18) was 10.2%, while 12% of adolescents
were infected with one of the types included in the
quadrivalent vaccine (HPV types 6, 11, 16 and 18).
After using both HPV DNA detection assays, only
one specimen had an unclassified HPV type.
Risk factors for HPV infection
Three different outcomes were analyzed: any HPV infection,
infection with a single HPV type, and infection with
multiple HPV types. The three outcomes were each
compared to participants with no infections. The
associations between baseline variables and HPV infection,
as well as the results of the multivariate analyses for all vari-
ables retained in the final regression models, are presented
in Tables 3, 4 and 5.
Having a number of lifetime sexual partners greater
than one was associated with a higher risk of any
HPV infection (adjusted OR: 4.9 [95% CI: 2.5–9.5])
(Table 3), single HPV infection (adjusted OR: 4.7
[95% CI: 2.4–9.1]) (Table 4), and multiple HPV infection
(adjusted OR: 3.7 [95% CI: 1.8–9.5]) (Table 5).
Risk factors for cytological abnormalities
The prevalence ratio for cytological abnormalities
between samples from adolescents infected with either
one or multiple HPV types was calculated. Participants
were categorized into either “negative for intraepithelial
Table 2 HPV prevalence in participants from central Brazil
HPV positive participants Multiple HPV positive participants
n % (95% CI) n % (95% CI)
HPV 121 28.0 (23.9-32.5) 54 100
One HPV type 67 15.5 (12.3-19.4) - -
Multiple HPV types 54 12.5 (9.6-16.1) - -
HR-HPV 107 24.8 (20.8-29.2) 53 98.1 (90.1-100.0)
LR-HPV 32 7.4 (5.2-10.4 19 5.8 (3.6-9.0)
HPV 16 29 6.7 (4.6-9.6) 21 38.9 (25.9-53.1)
HPV 51 22 5.1 (3.3-7.7) 18 33.3 (21.1-47.5)
HPV 31 20 4.6 (2.9-7.2) 12 22.0 (12.0-35.6)
HPV 52 18 4.2 (2.6-6.6) 10 18.5 (9.3-31.4)
HPV 18 15 3.5 (2.0-5.8) 12 22.2 (12.0-35.6)
HPV 53 11 2.5 (1.3-4.6) 11 20.4 (10.6-36.5)
HPV 58 10 2.3 (1.2-4.4) 8 14.8 (6.6-27.1)
HPV 39 9 2.1 (1.0-4,1) 8 14.8 (6.6-27.1)
HPV 6 7 1.6 (0.7-3.5) 6 11.1 (4.2-22.6)
HPV 45 6 1.4 (0.6-3.2) 1 1.9 (0.0-9.9)
HPV 66 6 1.4 (0.6-3.2) 3 5.6 (1.2-15.4)
HPV 73 6 1.4 (0.6-3.2) 2 3.7 (0.5-12.7)
HPV 42 5 1.2 (0.4-2.8) 3 5.6 (1.2-15.4)
HPV 54 5 1.2 (0.4-2.8) 2 3.7 (0.5-12.7)
HPV 26 4 0.9 (0.3-2.5) 2 3.7 (0.5-12.7)
HPV 33 4 0.9 (0.3-2.5) 3 5.6 (1.2-15.4)
HPV 56 4 0.9 (0.3-2.5) 2 3.7 (0.5-12.7)
HPV 68 4 0.9 (0.3-2.5) 3 5.6 (1.2-15.4)
HPV 40 3 0.7 (0.2-2.2) 1 1.9 (0.0-9.9)
HPV 84 3 0.7 (0.2-2.2) 3 5.6 (1.2-15.4)
HPV 35 2 0.5 (0.1-1.8) 2 3.7 (0.5-12.7)
HPV 70 2 0.5 (0.1-1.8) 0 -
HPV 55 2 0.5 (0.1-1.8) 1 1.9 (0.0-9.9)
HPV 61 2 0.5 (0.1-1.8) 0 -
HPV 62 2 0.5 (0.1-1.8) 2 3.7 (0.5-12.7)
HPV 59 1 0.2 (0.0-1.5) 1 1.9 (0.0-9.9)
HPV 82 1 0.2 (0.0-1.5) 1 1.9 (0.0-9.9)
HPV 11 1 0.2 (0.0-1.5) 0 -
HPV 89 1 0.2 (0.0-1.5) 1 1.9 (0.0-9.9)
HPV 44 1 0.2 (0.0-1.5) 0 -
HPV: human papillomavirus; CI: confidence interval; n: number of participants; HR-HPV: high-risk HPV; LR-HPV: low-risk HPV.
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Participants with positive HPV results were then clas-
sified into non-overlapping categories, and the impact
of multiple infections on cytological abnormalities
(excluding HPV 16) was analyzed (Table 6). The
prevalence ratio was 2.1 (95% CI: 1.1–4.0) for cytological
abnormalities associated with a single HPV type, and
was 6.4 (95% CI: 4.1–10.0) for multiple HPV types.The prevalence ratio when all adolescents infected
with HPV-16 were excluded was 2.2 (95% CI: 1.3–4.3)
for a single HPV type and 6.2 (95% CI: 3.7–7.1) for
multiple HPV types.
Discussion
This community-based study investigated patterns of HPV
infection in exfoliated cells from Brazilian adolescents
Figure 1 Absolute frequency of the 30 HPV types detected as single and multiple HPV infections (HPV: human papillomavirus;
*oncogenic types; dark bars represent multiple HPV types; dotted bars represent a single HPV type).
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prevalence of HPV infection in sexually active adolescents.
Moreover, it reaffirms the high rate of multiple HPV types,
which agrees with previous studies involving sexually active
adolescents and young women [4,6,14,26,27].
HR-HPV types were the most common HPV types
detected (88.4%), and they were similar to the HPV
types described in other studies [6,8,26,27]. HPV-16,
in particular, was the most common type detected in
cases of both single and multiple infections. The dis-
tribution of other HPV types differed from previous
studies [4,26,27]. In the present study, HPV-18 was
the fifth most prevalent type, behind types 16, 51, 31
and 52. More than one-third (36.4%) of HPV-positive
specimens exhibited HPV-16/18 dual infection. Differ-
ences in the prevalence and distribution of the individual
HPV types may be explained by the use of different
methods used to detect HPV, variability in the clinicalspecimens used, the age of the participants and regional
variation in the distribution of the types.
The HR-HPV types were detected in 80.6% of all
single-type infections, and in 98% of all multiple-type
infections. The high prevalence of multiple HPV types
may be because high-risk types are more likely to cause
persistent infections than low-risk types [4,12]. Furthermore,
the high prevalence of multiple HPV types may be related
to the increasing levels of estrogen exposure during pubertal
development. Previous studies suggest that the increased
levels of estrogen may modulate the immune response and
facilitate cervical ectropion and squamous metaplasia, both
of which add to the biological susceptibility of the uterine
cervix [28,29].
The present study correlated HPV infection with
the number of prior sexual partners, which produced
results consistent with previously published reports
[6,7,26], emphasizing once more the importance of sexual
Table 3 Factors associated with HPV infection
Variables HPV infection Total (%) OR (IC 95%) p Adjusted OR IC95% p
Age (years)
≤ 17 69 237 29.1 1.1 (0.7 – 1.7) 0.57 - -
> 17 52 195 26.7
Education (years)a
≤ 8 79 247 32.0 1.6 (1.0-2.5) 0.02 1.2 (0.6-2.2) 0.54
> 8 41 184 22.3
Marital status
Unmarried 93 291 32.0 1.9 (1.2-3.0) <0.01 1.1 (0.5-2.1) 0.76
Married 28 141 19.9
Smoking
Yes 22 50 44,0 2.2 (1.2-4.1) <0.01 1.7 (0.8-3.7) 0.15
No 99 382 25,9
Age at first intercourse (years)
10–15 80 264 30.3 1,3 (0,9-2,1) 0.18 0.8 (0.4-1.6) 0.59
16-19 41 168 24.4
Age at menarcheb (years)
13–17 56 207 27.1 0.9 (0.6-1.4) 0.70 - -
9-12 64 223 28.7
Condom use
Never/occasional 98 345 28.4 1.1 (0.6-1.8) 0.71 - -
Always 23 87 26.4
Number of lifetime sexual partners
> 1 88 199 44.2 4.8 (3.0-7.6) <0,001 4.9 (2.5-9.5) <0.01
1 33 233 14.2
New sexual partner in past 3 months
Yes 21 63 33.3 1.3 (0.7-2.4) 0.30 - -
No 100 369 27.1
Number of sexual partner in past 3 months
> 1 12 21 57.1 3.7 (1.5-9.0) <0.01 1.2 (0.3-4.2) 0.80
≤ 1 109 411 26.5
Age at first full-term pregnancy (years) c
No 70 252 27.8 1 0.31 - -
< 15 25 82 30.5 1.1 (0.6-1.9) 0.34 - -
≥ 15 24 94 25.5 0.9 (0.5-1.5)
C. trachomatis infection
Yes 23 60 38.3 1.7 (1.0-3.1) 0.05 1.0 (0.5-2.2) 0.96
No 98 372 26.3
HPV: Human papillomavirus; OR: odds ratio; CI: confidence interval; C. trachomatis: Chlamydia trachomatis. a one without information; b two without information;
c Four without information. The variables “Education”, “Marital status”, “Smoking”, “Age at first intercourse”, “Number of lifetime of sexual partners” and the
“Number of sexual partners in the past 3 months” were included in the multivariate model. The odds ratios have been adjusted for age as a continuous variable.
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infection with multiple HPV types has been found in
sexually active adolescents and young women [3-7].
However, it is uncertain whether the presence ofmultiple HPV types in adolescents is due to behav-
ioral characteristics or whether adolescents with mul-
tiple HPV types possess certain intrinsic biological
characteristics that increase susceptibility. The present
Table 4 Factors associated with single HPV infection
Variables Single HPV infection Total (%) OR (IC 95%) p Adjusted OR IC95% p
Age (years)
≤ 17 37 205 18.0 1.0 (0.6-1.8) 0.48 - -
> 17 30 173 17.3
Education (years)a
≤ 8 41 209 19.6 1.4 (0.8-2.4) 0.11 1.1 (0.6-2.1) 0.70
> 8 25 168 14.8
Marital status
Unmarried 48 246 19.5 1.4 (0.8-2.6) 0.13 1.3 (0.6-2.8) 0.48
Married 19 132 14.4
Smoking
Yes 14 42 33.3 2.7 (1.3-5.4) <0.001 1.4 (0.6-3.2) 0.37
No 53 336 15.8
Age at first intercourse (years)
10–15 44 228 19.3 1.3 (0.7-2.3) 0.19 0.8 (0.4-1.6) 0.53
16-19 23 150 15.3
Age at menarchea (years)
13–17 29 180 16.1 0.8 (0.5-1.4) 0.21 - -
9-12 38 197 19.2
Condom use
Never/occasional 52 299 17.4 0.9 (0.5-1.7) 0.42 - -
Always 15 79 19.0
Number of lifetime sexual partners
> 1 18 218 8.2 2.9 (1.6-5.5) <0.001 4.7 (2.4-9.1) <0.001
1 49 160 30.6
New sexual partner in past 3 months
Yes 8 50 16.0 0.8 (0.4-1.9) 0.37 - -
No 59 328 18.0
Number of sexual partner in past 3 months
> 1 12 61 7.4 1.2 (0.6-2.3) 0.32 - -
≤ 1 55 317 17.3
Age at first full-term pregnancy (years) b
No 34 216 15.7 1 0.12 1 0.81
< 15 19 89 21.3 1.4 (0.7-2.7) 0.36 0.8 (0.3-1.9) 0.63
≥ 15 12 69 17.4 1.1 (0.5-2.3) 0.6 (0.2-1.4)
C. trachomatis infection
Yes 11 48 22.9 1.4 (0.7-3.0) 0.27 - -
No 56 330 16.9
HPV: Human papillomavirus; OR: odds ratio; CI: confidence interval; C. trachomatis: Chlamydia trachomatis. a one without information; b Four without information.
The variables “Education”, “Marital status”, “Smoking”, “Age at first intercourse”, “Number of lifetime of sexual partners” and the “Age at first full-term pregnancy”
were included in the multivariate model. The odds ratios have been adjusted for age as a continuous variable.
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infection were similar to the risk factors for any HPV
infection and single HPV infection, which agrees with
previous studies of sexually active adolescents andyoung women [6,7]. However, the cross- sectional
design of this study will not be able to adequately
answer that if the risk factors for multiple HPV infec-
tion were distinct from risk factors for any HPV
Table 5 Factors associated with multiple HPV infection
Variables Multiple HPV infection Total (%) OR (IC 95%) p Adjusted OR IC95% p
Age (years)
≤ 17 32 200 16.0 1.3 (0.7-2.2) 0.28 - -
> 17 22 165 13.3
Education (years)
≤ 8 38 206 18.4 2.0 (1.1-3.8) 0.02 1.8 (0.8-3.7) 0.11
> 8 16 159 10.0
Marital status
Unmarried 45 243 18.5 2.8 (1.3-6.0) 0.006 2.2 (0.8-5.6) 0.10
Married 9 122 7.4
Smoking
Yes 8 36 22.2 1.7 (0.7-4.1) 0.19 0.9 (0.3-2.3) 0.82
No 46 329 14.0
Age at first intercourse (years)
10–15 36 220 16.3 1.4 (0.7-2.5) 0.30 - -
16-19 18 145 12.4
Age at menarchea (years)
13–17 27 78 15.1 1.1 (0.6-1.9) 0.76 - -
9-12 26 185 14.0
Condom use
Never/occasional 46 293 15.7 1.5 (0.7-3.3) 0..32 - -
Always 8 72 11.1
Number of lifetime sexual partners
> 1 39 150 26.0 4.7 (2.4-8.9) <0.001 3.7 (1.8-7.5) <0.001
1 15 215 7.0
New sexual partner in past 3 months
Yes 13 55 23.6 2.0 (1.0-4.1) 0.04 0.6 (0.2-1.9) 0.42
No 41 310 13.2
Number of sexual partner in past 3 months
> 1 8 17 47.0 5.5 (2.1-15.9) 0.001 0.3 (0.1-1.1) 0.07
≤ 1 46 348 13.2
Age at first full-term pregnancy (years) a
No 36 218 16.5 1 - 1 0.40
< 15 13 70 18.6 1.1 (0.6-2.3) 0.34 0.6 (0.3-1.6) 0.35
≥ 15 5 75 6.7 0.3 (0.1-0.9) 0.01 1.7 (0.5-5.7)
C. trachomatis infection
Yes 12 49 2.1 (1.0-4.4) 0.04 1.4 (0.6-3.2) 0.36
No 42 316
HPV: Human papillomavirus; OR: odds ratio; CI: confidence interval; C. trachomatis: Chlamydia trachomatis. a two without information. The variables “Education”,
“Marital status”, “Smoking”, “Number of lifetime of sexual partners”, “New sexual partner in past 3 months”, “Number of sexual partner in past 3 months”,
“Age at first full-term pregnancy”, and “C. trachomatis infection” were included in the multivariate model. The odds ratios have been adjusted for age as
a continuous variable.
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teenagers come and go. Those classified as “single
infection” during this study may well have had a multiple
infections a few weeks prior, and vice versa.The role of multiple HPV infections in cervical carcino-
genesis is still controversial. Some studies have reported
an association between multiple HPV infections and a
higher risk of cytological abnormalities and cervical
Table 6 Association between cytological abnormalities
and HPV infection (n = 432)
Cytological
abnormalities
PR (95% CI) p
Positive Total
HPV infection
Negative 26 311 - -
One type 12 67 2.1 (1.1-4.0) 0.02
Multiple types 29 54 6.4 (4.1-10.0) <0.01
HPV infection without HPV-16
Negative 26 311 - -
One 11 59 2.2 (1.2-4.3) 0.03
Multiple types 17 33 6.2 (3.7-10.1) <0.01
HPV: human papillomavirus; n: number; PR: prevalence ratios.
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ent [2,5,17], and these correlations are not associated with
viral persistence, compared with infection due to one
HPV type [9,17]. The present study shows a significant as-
sociation between cytological abnormalities and
detection of both single and multiple HPV types;
however, this association was significantly stronger for
infections with multiple HPV types, as reported in
other studies [14,15].
This association could be explained by the elevated
prevalence of HR-HPV types detected in samples with
multiple infections in this study. HR-HPVs are often
present as persistent infections, representing the main
risk factor for the development of lesions [12]. However,
there is some evidence that infection with multiple HPV
types confers an increased risk for the development
and/or progression of lesions, regardless of the per-
sistence of HPV infections [15]. In contrast, the low-
grade cytological abnormalities found in this study
may reflect the viral load resulting from productive
infections, many of which tend to regress over time,
thereby resulting in less clearly identifiable lesions.
Additionally, the excess risk of cytological abnormalities
resulting from multiple infections remained even after
excluding the adolescents who harbored HPV-16, a
similar finding to the Ludwig-McGill cohort study
[15]. The smaller sample size for multiple HPV infection,
without those with HPV-16, may have limited the power
of the study to detect large differences.
A potential limitation of this investigation was the
reliance on cytological samples of cervical lesions
without corresponding biopsy results. The cytological
screening interpretation presents known problems
with specimen collection, smear preparation and inter-
observer reproducibility in all cytological categories [30,31].
The US multicenter clinical trial, “ASCUS-LSIL Triage
Study” (ALTS), showed that inter-observer reproducibilityof cytological interpretation of a large series of speci-
mens was only moderate and the greatest source of
disagreement involved interpretation of atypical squa-
mous cells of undetermined significance (ASC-US), of
which 37% were HPV positive [30]. In the present
study, 61.0% of samples with cytological abnormalities
and 47.8% of ASC-US samples were positive for HPV.
This reflects careful cytological assessment in a refer-
ence laboratory following strict quality control guide-
lines. This strategy was adopted to avoid unnecessary
biopsies for lesions that have a higher potential for
spontaneous regression.
Another potential limitation of this study was the esti-
mation of prevalence by cross-sectional detection of
type-specific HPV infections, which may underestimate
the cumulative cytological abnormalities resulting from
exposure to different HPV types over time. Furthermore,
this investigation relied on the accuracy of the memories
of subjects for precise information about their sexual
and reproductive history.
Conclusions
The detection of any, single or multiple HPV types in
cervical specimens of adolescents was associated with
the number of lifetime sexual partners. These findings
also show that in adolescents, infection with multiple
HPV types is associated with the development of more
cervical cytological abnormalities than infection with a
single HPV type.
By providing data on the epidemiology of HPV infection
with multiple HPV types in adolescents, these results may
inform the planning and the interpretation of models evalu-
ating the impact and cost effectiveness of vaccines. These
estimates, obtained prior to the introduction of HPV vac-
cination, provide a baseline for monitoring and surveillance
of the effectiveness of this primary prophylactic interven-
tion in vaccinated and unvaccinated adolescents. The high
rate of HPV detection in adolescents emphasizes the
advantages of early vaccination, prior to the onset of sexual
activity. Furthermore, the high prevalence of minor cyto-
logical abnormalities, which tend to regress with time, rein-
forces the recommendation not to include teenagers in
cervical cytology screening programs. Although most cyto-
logical abnormalities in adolescents may regress over time,
there is a need for longitudinal studies to assess the cumu-
lative influence of infection with multiple HPV types in the
progression of cervical lesions with increasing age.
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